The novel nomogram of Gleason sum upgrade: Possible application for the eligible criteria of low dose rate brachytherapy

International Journal of Urology

Volumn 17, Issue 10, 2010, Pages 862-868

  Budäus, Lars ^a,c   Graefen, Markus ^a   Salomon, Georg ^a   Isbarn, Hendrik ^b   Lughezzani, Giovanni ^c   Sun, Maxine ^c   Chun, Felix Kh ^b   Schlomm, Thorsten ^a   Steuber, Thomas ^a   Haese, Alexander ^a   Koellermann, Jens ^b   Sauter, Guido ^b   Fisch, Margit ^b   Heinzer, Hans ^a   Huland, Hartwig ^a   Karakiewicz, Pierre I ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Department of Urology ^*  (Germany)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

decision curve analysis; Gleason sum upgrading; low dose rate brachytherapy; prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; DISEASE SEVERITY; GLEASON SCORE; HUMAN; LOW DOSE RATE BRACHYTHERAPY; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; NOMOGRAM; ORGAN SIZE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

AGED; BIOPSY, NEEDLE; BRACHYTHERAPY; DECISION SUPPORT TECHNIQUES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SEVERITY OF ILLNESS INDEX;

EID: 77957253060     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02615.x     Document Type: Article

References (19)

1. (ACr). AcoR. Practice guideline for transperineal permanent brachytherapy of prostate cancer. VA R, editor.: American College of Radiology (ACR); 2005. p7 p.
2. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother. Oncol. 2000 57 : 315 21.
3. Nag S, Beyer D, Friedland J, Grimm P, Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1999 44 : 789 99. (Pubitemid 29284127)
4. King CR. Patterns of prostate cancer biopsy grading: trends and clinical implications. Int. J. Cancer 2000 90 : 305 11.
5. D'Amico AV, Renshaw AA, Arsenault L, Schultz D, Richie JP. Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. Int. J. Radiat. Oncol. Biol. Phys. 1999 45 : 841 6. (Pubitemid 29525444)
6. Chun FK, Steuber T, Erbersdobler A et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur. Urol. 2006 49 : 820 6.
7. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 1974 111 : 58 64.
8. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Making 2006 26 : 565 74.
9. Kulkarni GS, Lockwood G, Evans A et al. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy. Cancer 2007 109 : 2432 8. (Pubitemid 46906461)
10. Paulson DF. Impact of radical prostatectomy in the management of clinically localized disease. J. Urol. 1994 152 (5 Pt 2 1826 30.
11. Freedland SJ, Isaacs WB, Platz EA et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J. Clin. Oncol. 2005 23 : 7546 54.
12. Turley RS, Hamilton RJ, Terris MK et al. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. J. Urol. 2008 179 : 523 7 discussion 527-8.
13. Turley RS, Terris MK, Kane CJ et al. The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database. BJU Int. 2008 102 : 1074 9.
14. Capitanio U, Karakiewicz PI, Valiquette L et al. Biopsy core number represents one of foremost predictors of clinically significant Gleason sum upgrading in patients with low-risk prostate cancer. Urology 2009 73 : 1087 91.
15. Tilki D, Schlenker B, John M et al. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series. Urol. Oncol. 2009 [Epub Ahead of Print]
16. Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J. Urol. 2008 180 : 1964 7 discussion 1967-8.
17. Dong F, Jones JS, Stephenson AJ, Magi-Galluzzi C, Reuther AM, Klein EA. Prostate cancer volume at biopsy predicts clinically significant upgrading. J. Urol. 2008 179 : 896 900 discussion.
18. Heidenreich A, Aus G, Bolla M et al. EAU guidelines on prostate cancer. Eur. Urol. 2008 53 : 68 80. (Pubitemid 350166735)
19. Dotan ZA, Bianco FJ, Jr., Rabbani F et al. Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J. Clin. Oncol. 2005 23 : 1962 8. (Pubitemid 46211375)